ENTELLUS MED INC's ticker is ENTL and the CUSIP is 29363K105. A total of 73 filers reported holding ENTELLUS MED INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $38,581,000 | +7.4% | 2,089,974 | -3.7% | 14.72% | +41.9% |
| Q2 2017 | $35,931,000 | +34.5% | 2,169,729 | +12.1% | 10.38% | +16.5% |
| Q1 2017 | $26,714,000 | +88.8% | 1,935,809 | +159.5% | 8.91% | +61.4% |
| Q4 2016 | $14,151,000 | -8.9% | 745,983 | +6.5% | 5.52% | -13.3% |
| Q3 2016 | $15,532,000 | – | 700,285 | – | 6.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,956,456 | $48,960,000 | 52.70% |
| Discovery Group I, LLC | 2,169,729 | $35,931,000 | 10.38% |
| Essex Woodlands Management, Inc. | 3,231,656 | $53,516,000 | 9.68% |
| Archon Capital Management LLC | 478,820 | $7,929,000 | 6.46% |
| First Light Asset Management, LLC | 512,416 | $8,486,000 | 2.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 341,468 | $5,655,000 | 2.15% |
| Ghost Tree Capital, LLC | 375,000 | $6,210,000 | 1.29% |
| PERKINS CAPITAL MANAGEMENT INC | 68,316 | $1,131,000 | 1.25% |
| Cypress Capital Management LLC (WY) | 63,540 | $1,052,222,000 | 1.21% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 35,000 | $580,000 | 0.66% |